Cases
Representative Matters: American Biltrite Inc. et al.: v. Linatex Limited Plc, et al., Case No. 1:19-cv-12466-NMG (D.Mass, J.Gorton). Represented plaintiff in trademark cancellation suit pursuant to 15 U.S.C. 1119
1120 for fraud
lack of acquired distinctiveness. Case resolved on terms client found favorable.
Wright Medical Technology, Inc.: v. Paragon 28 LLC, Case No. 1:18-cv-010691-STV (D.Colo.). Represent Wright Medical in a patent infringement
trade secret misappropriation suit involving ten patents related to bone plating systems
related distraction device. Matter is currently pending.
Nuance Communications, Inc. v.
MModal LLC:, Case No. 1:17-cv-01484-JFB-SRF (D.Del.). Represent MultiModal in a patent infringement suit filed by Nuance Communications involving five patents related to speech recognition
transcription technology. Matter is currently pending.
MModal Services, Ltd.: v. Nuance Communications, Inc., Case No. 1:18-cv-00901-SJC (N.D.Ga.). Represent MModal Services, Ltd. in a patent infringement suit filed against Nuance Communications involving five patents related to speech recognition
transcription technology. Matter is currently pending.
Alnylam Pharmaceuticals v.
Dicerna Pharmaceuticals:, Case No. 15-cv-4126 (Commonwealth of Massachusetts - Leibensperger). Member of the trial team representing Dicerna in a trade secret misappropriation suit concerning RNA interference technology. Resolved before trial on terms the client found favorable.
Dicerna Pharmaceuticals: v. Alnylam Pharmaceuticals, Case No. 17-cv-11466 (D.Mass - NMG). Member of the trial team representing Dicerna in an antitrust suit brought against Alnylam Pharmaceuticals concerning RNA interference technology. Resolved before trial on terms the client found favorable.
Spineology Inc. v.
Wright Medical Technology, Inc.:, Case No. 15-cv-00180 (D.Minn.- Erickson). Member of the trial team representing Wright Medical in a patent infringement litigation concerning bone reaming device used during hip replacement
spinal surgery. Won summary judgment of noninfringement. The case is currently on appeal before the Federal Circuit.
Represented
Wockhardt: in Paragraph IV litigation involving Otsuka's oral Abilify. Negotiated a settlement
license agreement permitting entry into the market prior to the expiration of the Orange Book Patents.
AngleFix Technology, Inc. v.
Wright Medical Technology, Inc.:, Case No. 13-cv-02407 (W.D. Tenn.- J.McCalla). Member of the trial team representing Wright Medical in a patent infringement litigation concerning bone plates
screws used during bone repair procedures. Most claims held invalid by PTAB
granted summary judgment of invalidity
noninfringement with respect to remaining claims.
Howmedica Osteonics Corp. et al. v.
Wright Medical Technology, Inc.:, 2:11-cv-6499 (D.N.J. 2011) Represented defendant Wright Medical Technology, Inc. in a patent infringement matter relating to acetabular cup assembly with selected bearing.
Wright Medical Technology, Inc. v. OsteoImplant Technology, Inc. :, Case No. 04-cv-1167 (D.N.J.- M. Bumb). Patent infringement litigation with tens of millions at stake concerning modular hip replacement prostheses. Settled on terms the client found favorable.
Howmedica Osteonics v.
Wright Medical Technology, Inc.:, Case No. 00-cv-1167 (D.N.J.- S. Wigenton). Won summary judgment in the District of New Jersey in a patent infringement litigation concerning artificial knee implant technology with tens of millions at stake. Decision affirmed by Federal Circuit.
Wright Medical Technologies Inc.: v. LifeCell Corp., (2007 AAA Arbitration). Represented Wright Medical in a five-day arbitration concerning distribution rights to LifeCell's GraftJacket xenograft tissue product.
Teva Pharmaceuticals et al. v.
Amneal Pharmaceuticals, et al: ., 17-00074 (D.Del. G. Sleet). Currently representing Amneal Pharmaceuticals as declaratory judgment plaintiff against Teva in litigation involving method of manufacturing COPAXONE, the active ingredient of which is glatiramer acetate.
Elli Lilly, et al. v.
Amneal Pharmaceuticals Inc.: et al ., 13-00851 (D.Ind. S.Barker). Represented Amneal Pharmaceuticals in litigation involving AXIRON, the active ingredient of which is testosterone.
Abbott Laboratories v.
S
oz Inc.:, 10-538 (D.Del. - S. Robinson). Representing S
oz in ANDA litigation regarding NIASPAN, the active ingredient of which is niacin.
King Pharmaceuticals, Inc. et al. v.
Actavis Inc.:, et al., Case No. 07-05041 (D.N.J. - G. Brown). Represented Actavis in ANDA litigation regarding AVINZA, the active ingredient of which is morphine sulfate.
Wyeth v.
Apotex Inc.: et al., Case No. 08-CIV-22308 (S.D.Fla. - F. Moreno). Represented Apotex in ANDA litigation regarding EFFEXOR XR (venlafaxine hydrochloride). Settled after two phases of trial were completed.
Sepracor v.
Wockhardt:, Case No. 09-CV-1302 (D.N.J. - D.Cavanaugh). Represented Wockhardt in ANDA litigation regarding LUNESTA, the active ingredient of which is eszopiclone. Settled prior to trial on terms the client found favorable.
Pfizer, Inc. v.
Wockhardt:, Case No. 12-CV-817 (D.Del.- S. Robinson). Representing Wockhardt in ANDA litigation regarding PRISTIQ, the active ingredient of which is desvenlafaxine.
Teva v.
Watson:, Case No. 10-CV-5078 (D.N.J. - C.Cecchi). Represented Watson Pharmaceuticals, Inc. in Hatch-Waxman Litigation against Teva Pharmaceutical Industries Ltd. concerning the Parkinson's disease drug AZILECT, the active ingredient of which is rasagiline. The matter was settled during trial.
Member of a team of lawyers representing a Fortune 100 pharmaceutical company in a multibillion-dollar patent
antitrust litigation arising out of technology relating to the pharmaceutical application of recombinant proteins.
Represented one of the largest manufacturers
distributors of lighting products in the United States. Representation involves several matters dealing with both design
utility patents concerning fluorescent
halogen light bulbs.
Successfully opposed summary judgment on behalf of a small independent inventor against a Fortune 200 pharmaceutical company in a l
mark decision relating to correction of patent inventorship.
